Establishing Centers of Excellence for Axial Spondyloarthritis in Latin America: Consensus Recommendations From the REAL-PANLAR Group
Related Experiment Video
Updated: Jan 11, 2026

A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.
Published on: February 14, 2021
Rodrigo Garcia-Salinas1, Xenofon Baraliakos2, Fernando Sommerfleck3
1R. Garcia-Salinas, MD, Rheumatology Unit, Hospital Italiano de La Plata, Universidad Nacional de La Plata, La Plata, Argentina.
Objective:
Axial spondyloarthritis (axSpA) is a chronic inflammatory condition primarily affecting the sacroiliac joints and spine, often complicated by extramusculoskeletal manifestations such as uveitis, psoriasis, and inflammatory bowel disease. Delayed diagnosis due to nonspecific symptoms, coupled with regional disparities in healthcare infrastructure in Latin America, exacerbates disease burden, emphasizing the need for specialized care. This project aimed to develop a regional consensus for establishing Centers of Excellence (COEs) in axSpA management.
Methods:
A Delphi methodology was employed, involving 16 rheumatology experts from 12 Latin American countries. A structured process included a systematic literature review, questionnaire validation, and consensus building during a virtual and in-person meeting. Criteria were categorized into initial premises, structure, processes, and outcomes, guided by the Donabedian quality evaluation framework.
Results:
The consensus established 3 COE classifications-standard, optimal, and model-defined by resource availability and care standards. Human resources criteria highlighted multidisciplinary teams, including rheumatologists, physiatrists, and dermatologists, with agreement rates ranging from 70.6% to 100%. Structural requirements, such as electronic health systems for traceability and continuous training, achieved consensus levels between 81.3% and 100%. Process-related criteria emphasized comprehensive care models, treat-to-target strategy implementation, and validated clinimetric tools (eg, Ankylosing Spondylitis Disease Activity Score, Bath Ankylosing Spondylitis Disease Activity Index), with approval ratings of 70.6% to 100%.
Conclusion:
This consensus establishes a scalable framework for COEs in axSpA in Latin America, balancing high-quality care standards with regional healthcare limitations.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Rheumatic Heart Disease III: Medical Management
Atherosclerosis III: Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Chronic Pancreatitis II: Collaborative Care
Assessment:
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

